tiprankstipranks

Robinhood - New Portfolio

Orville

Robinhood
Individual Investor
Ranked #632,629 out of 781,066 TipRanks' Investors
Success Rate
26%
8 out of 31
profitable transactions
Average Return
-36.73%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 18.96%
6-Month Return▼ 15.68%
12-Month Return▼ 26.00%
YTD Return▲ 10.64%
Total Return▼ 76.44%

Best Trade

Opened at
Closed at-
Gain▲ 196.83%

Bio

Performance

26.04%0-26.04%
▲ 9.79%
▲ 3.53%
▼ 16.42%
Jun 2024
▲ 8.13%
▲ 1.21%
▲ 4.57%
Jul 2024
▼ 13.14%
▲ 2.34%
▼ 10.65%
Aug 2024
▲ 2.93%
▲ 2.10%
▼ 18.47%
Sep 2024
▲ 10.00%
▼ 0.89%
▲ 6.94%
Oct 2024
▲ 26.04%
▲ 5.96%
▲ 3.76%
Nov 2024
▲ 5.93%
▼ 2.41%
▼ 5.60%
Dec 2024
▲ 11.17%
▲ 1.96%
▲ 10.64%
Jan 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 9.79%▲ 3.53%▼ 16.42%
▲ 8.13%▲ 1.21%▲ 4.57%
▼ 13.14%▲ 2.34%▼ 10.65%
▲ 2.93%▲ 2.10%▼ 18.47%
▲ 10.00%▼ 0.89%▲ 6.94%
▲ 26.04%▲ 5.96%▲ 3.76%
▲ 5.93%▼ 2.41%▼ 5.60%
▲ 11.17%▲ 1.96%▲ 10.64%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Roundhill N-100 0DTE Covered Call Strategy ETF
0%
▲ 4.52%
1
Open
Oct 28, 2024
Werewolf Therapeutics
0%
▼ 55.07%
1
Open
Oct 28, 2024
Bright Minds Biosciences
0%
▼ 22.80%
1
Open
Oct 28, 2024
ARK 21Shares Bitcoin ETF Ben of Int
0%
▲ 72.93%
1
Open
Feb 28, 2024
Ocugen
0%
▼ 24.55%
1
Open
Feb 28, 2024
Vor Biopharma
0%
▼ 38.43%
1
Open
Feb 28, 2024
Viracta Therapeutics
0%
▼ 81.12%
1
Open
Feb 28, 2024
Unity Biotechnology
4.78%
▼ 49.83%
2
Buy
May 18, 2023
EyePoint Pharmaceuticals
61.97%
▲ 109.42%
2
Buy
May 18, 2023
Tenaya Therapeutics
6.77%
▼ 79.90%
2
Buy
May 18, 2023
IN8bio
1.23%
▼ 89.76%
2
Buy
May 18, 2023
Lantheus
25.26%
▼ 4.74%
1
Open
May 18, 2023
Antero Resources
▲ 19.22%
2
Close
May 16, 2023
SoFi Technologies
▼ 72.07%
2
Close
May 16, 2023
Camber Energy
▼ 99.30%
2
Close
May 16, 2023
Amyris
▼ 95.68%
2
Close
May 16, 2023
Lucid Group
▼ 71.56%
2
Close
May 16, 2023
Nio
▼ 77.43%
2
Close
May 16, 2023
Amazon
▲ 19.52%
2
Close
May 16, 2023
Genius Group Limited
▼ 69.98%
2
Close
May 16, 2023